Several companies claim to be engaged in the development / manufacturing of various types of autoinjectors / claims Roots Analysis

In addition to enabling patients to self-medicate, these devices are designed to ensure safety during the dosing process and promote compliance to prescribed therapeutic regimens. Moreover, the adoption of autoinjectors, and other self-injection products, has enabled significant cost savings for end users by eliminating the need to visit hospitals / out-patient clinics for dosing.

 

To order this 600+ page report, which features 360+ figures and 350+ tables, please visit this https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

• An overview of the current market landscape of companies engaged in developing and / or manufacturing autoinjectors, providing information on the usability (disposable and reusable), type of primary drug container (cartridge, syringe and vial), volume of container, type of dose (fixed and variable), route of administration (intradermal, intramuscular and subcutaneous), actuation mechanism (automatic and manual) and feedback mechanism integrated in the device. It also provides details on the developers, highlighting their year of establishment, company size (small-sized, mid-sized and large), location of headquarters and location of manufacturing facilities
• Information on companies that are developing drugs in combination with autoinjectors, featuring details on initial year of approval (for marketed products), phase of development, usability of the device, route of administration (intracavernous, intramuscular and subcutaneous), type of drug molecule (antibody, peptide, protein and small molecule), dose strength, therapeutic area and other approved dosage forms (for marketed products). In addition, the section provides details on the company, including year of establishment, company size and location of headquarters
• A competitiveness analysis of various disposable and reusable autoinjectors, taking into consideration supplier power (based on year of establishment and company size) and key product specifications, such as route of administration, primary drug container used, injector actuation mechanism, type of dose and user friendliness of the product.
• An in-depth analysis of the various patents that have been filed / granted related to autoinjectors, till August 2019, highlighting details on key parameters, such as type of patent, publication year, issuing authority, CPC classification, emerging focus areas and leading industry players (on the basis of number of patents). It also includes a detailed patent benchmarking and an insightful valuation analysis.
• A detailed brand positioning analysis of leading industry players (shortlisted on the basis of strength of product portfolio), highlighting the current perceptions regarding their proprietary brands by taking into consideration several relevant aspects, such as strength and diversity of product portfolio, route of administration, actuation mechanism, geographical presence / reach and supplier power of each company.

The USD 2.5 billion (by 2030) financial opportunity within the global autoinjectors market has been analyzed across the following segments:

• Usability
• Disposable
• Reusable
• Route of administration
• Subcutaneous
• Intramuscular
• Type of molecule
• Antibody
• Peptide
• Protein
• Small molecule
• Therapeutic indication
• Anaphylaxis
• Diabetes
• Migraine
• Multiple sclerosis
• Rheumatoid arthritis
• Other indications
• Key geographical regions
• North America
• Europe
• Asia-Pacific
• Rest of the World

 

The Global Autoinjectors Market (3rd Edition), 2020-2030. report features the following companies, which we identified to be key players in this domain:

• Antares Pharma
• Consort Medical (Previously Bespak)
• DALI Medical Devices
• Elcam Medical (E3D Elcam Drug Delivery Devices)
• Jiangsu Delfu Medical Devices
• Oval Medical Technologies
• Owen Mumford
• SHL Group
• Union Medico®
• Ypsomed

 

Table of Contents

 

1. Preface

2. Executive Summary

3. Introduction
 

4. Primary Drug Containers
 

5. Autoinjectors: Current Market Landscape
 

6. Product Competitiveness Analysis
 

7. Brand Positioning of Key Industry Players
 

8. Patent Analysis
 

9. Therapeutic Products Available in Autoinjectors
 

10. Case Study: Autoinjector-based Combination Products and Affiliated Therapeutic Areas
 

11. Likely Drug Candidates for Delivery Via Autoinjectors
 

12. Key Players
 

13. Emerging Players
 

14. KOL Analysis

 

15. SWOT Analysis

 

16. Case Study: Medical Device Contract Service Providers

 

17. Market Sizing and Opportunity Analysis

 

18. Conclusion

 

19. Interview Transcripts

 

20. Appendix 1: Tabulated Data

 

21. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

[email protected]